Can we predict who ketamine helps? new study aims to find out
NCT ID NCT05625555
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to find which patients with treatment-resistant depression are most likely to get relief from a single low dose of IV ketamine. Researchers will use interviews, questionnaires, brain wave tests, and computer tasks to look for clues. The goal is to make this treatment safer and more cost-effective by giving it to those who need it most.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIPOLAR DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mood Disorders Program
Halifax, Nova Scotia, B3H2E2, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a common antibiotic and supplement lift bipolar depression?
- Brain markers may reveal who responds best to suicide treatments
- Can a tailored self-management program improve health outcomes for those with serious mental illness?
- Digital sleep and mood programs put to the test for breast cancer survivors
- Antidepressants may rewire how the brain perceives control
- Brain scans may predict which kids respond to family therapy for depression